Compare Bandhan BSE Healthcare Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.02 | 1.86 |
NAV | ₹9.93 | ₹37.51 |
Fund Started | 21 Aug 2024 | 25 Jun 2018 |
Fund Size | ₹18.09 Cr | ₹6455.55 Cr |
Exit Load | Exit load of 0.25%, if redeemed within 15 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.02
1.86
NAV
₹9.93
₹37.51
Fund Started
21 Aug 2024
25 Jun 2018
Fund Size
₹18.09 Cr
₹6455.55 Cr
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
Exit load of 1% if redeemed within 15 days.
1 Year | -1.44% | -1.13% |
3 Year | - | 25.33% |
5 Year | - | 16.15% |
1 Year
-1.44%
-1.13%
3 Year
-
25.33%
5 Year
-
16.15%
Equity | 100.00% | 97.87% |
Cash | 0.00% | 2.13% |
Equity
100.00%
97.87%
Cash
0.00%
2.13%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 14.10% |
Max Healthcare Institute Ltd. | 6.27% |
Cipla Ltd. | 6.22% |
Divi's Laboratories Ltd. | 6.02% |
Dr. Reddy's Laboratories Ltd. | 5.59% |
Apollo Hospitals Enterprise Ltd. | 5.38% |
Lupin Ltd. | 3.67% |
Fortis Healthcare Ltd. | 3.49% |
Laurus Labs Ltd. | 2.92% |
Torrent Pharmaceuticals Ltd. | 2.85% |
Sun Pharmaceutical Industries Ltd. | 12.05% |
Cipla Ltd. | 7.90% |
Dr. Reddy's Laboratories Ltd. | 7.82% |
Divi's Laboratories Ltd. | 7.10% |
Mankind Pharma Ltd. | 6.44% |
Lupin Ltd. | 5.78% |
Aurobindo Pharma Ltd. | 5.19% |
Alkem Laboratories Ltd. | 3.66% |
Cohance Lifesciences Ltd. | 3.01% |
Syngene International Ltd. | 2.98% |
Name | Nemish Sheth | - |
Start Date | 13 Feb 2025 | - |
Name
Nemish Sheth
-
Start Date
13 Feb 2025
-
Description | The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 21 Aug 2024 | 25 Jun 2018 |
Description
The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
21 Aug 2024
25 Jun 2018